Premarket Mover: F-Star Therapeutics Inc (FSTX) Down 1.93%

Friday, February 24, 2023 07:54 AM | InvestorsObserver Analysts

Mentioned in this article

Premarket Mover: F-Star Therapeutics Inc (FSTX) Down 1.93%

F-Star Therapeutics Inc (FSTX) has fallen Friday morning, with the stock falling -1.93% in pre-market trading to 5.6. FSTX's short-term technical score of 77 indicates that the stock has traded more bullishly over the last month than 77% of stocks on the market. In the Biotechnology industry, which ranks 125 out of 146 industries, F-Star Therapeutics Inc ranks higher than 83% of stocks. F-Star Therapeutics Inc has fallen 2.56% over the past month, closing at $4.21 on January 27. During this period of time, the stock fell as low as $4.11 and as high as $5.74. FSTX has an average analyst recommendation of Sell. The company has an average price target of $7.00.

FSTX has an Overall Score of 53. Find out what this means to you and get the rest of the rankings on FSTX!

See Full FSTX Report

F-Star Therapeutics Inc has a Long-Term Technical rank of 45. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 55% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, FSTX ranks better than 132% of stocks.

Important Dates for Investors in FSTX:

-F-Star Therapeutics Inc is set to release earnings on 3/13/2023. Over the last 12 months, the company has reported EPS of $-1.82. -We do not have a set dividend date for F-Star Therapeutics Inc at this time. Click Here To Get The Full Report on F-Star Therapeutics Inc (FSTX)